Ratios Reveal: Breaking Down Psyence Biomedical Ltd (PBM)’s Financial Health

Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.

Psyence Biomedical Ltd (NASDAQ: PBM) closed the day trading at $1.84 down -3.66% from the previous closing price of $1.91. In other words, the price has decreased by -$3.66 from its previous closing price. On the day, 0.2 million shares were traded. PBM stock price reached its highest trading level at $1.98 during the session, while it also had its lowest trading level at $1.78.

Ratios:

For a better understanding of PBM, let’s look at its different ratios.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PBM now has a Market Capitalization of 8145919 and an Enterprise Value of 31563022.

Stock Price History:

The Beta on a monthly basis for PBM is -0.44, which has changed by -0.9978095 over the last 52 weeks, in comparison to a change of 0.23806548 over the same period for the S&P500. Over the past 52 weeks, PBM has reached a high of $945.15, while it has fallen to a 52-week low of $1.51. The 50-Day Moving Average of the stock is -46.13%, while the 200-Day Moving Average is calculated to be -94.05%.

Shares Statistics:

Over the past 3-months, PBM traded about 2.40M shares per day on average, while over the past 10 days, PBM traded about 284810 shares per day. A total of 0.72M shares are outstanding, with a floating share count of 0.55M. Insiders hold about 23.47% of the company’s shares, while institutions hold 5.49% stake in the company. Shares short for PBM as of 1734048000 were 137684 with a Short Ratio of 0.06, compared to 1731628800 on 10984. Therefore, it implies a Short% of Shares Outstanding of 137684 and a Short% of Float of 17.69.

Earnings Estimates

The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.

Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0.

Most Popular